FDA Adverse Event Injury Summary report: N

TRU PATH BIOPSY NEEDLE

MDR report key: 1375567 · Received May 5, 2009

Report

Report Number
3005099803-2009-02246
Event Type
Injury
Date Received
May 5, 2009
Date of Event
April 1, 2009
Report Date
April 7, 2009
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
FCG
PMA / PMN Number
K050120
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MDR WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A TRUPATH PROSTATE BIOPSY NEEDLE WAS USED DURING A TRANSRECTAL PROSTATE BIOPSY PROCEDURE IN 2009. ACCORDING TO THE COMPLAINANT, THE PROCEDURE WAS COMPLETED WITH NO PATIENT COMPLICATIONS. THE PATIENT WAS PRESCRIBED PROPHYLACTIC CIPRO PRIOR TO THE PROCEDURE. THE PATIENT REPORTED TO THE PHYSICIAN THE FOLLOWING MONTH, STATING HE WAS HAVING BURNING DURING URINATION, SWEATING, AND CHILLS. THE PHYSICIAN PRESCRIBED SEPTRA TO TREAT A SUSPECTED INFECTION. ACCORDING TO THE COMPLAINANT, THE PATIENT'S SYMPTOMS CONTINUED TO DECLINE AND HE WAS ADMITTED TO THE HOSPITAL FOR ADMINISTRATION OF INTRAVENOUS ANTIBIOTICS. THE PATIENT RECOVERED AND WAS DISCHARGED FROM THE HOSPITAL AFTER FOUR DAYS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TRU PATH BIOPSY NEEDLE FCG BOSTON SCIENTIFIC CORPORATION M0065001151 11808082

Patients

Seq Age Sex Outcome Treatment
1 60 YR Hospitalization| R